We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

12 hedge funds and large institutions have $105K invested in AIM ImmunoTech in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

63% less funds holding

Funds holding: 32 → 12 (-20)

82% less capital invested

Capital invested by funds: $590K → $105K (-$485K)

91% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 22

Holders
12
Holders Change
-20
Holders Change %
-62.5%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
2
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Corient Private Wealth
Corient Private Wealth
Florida
+$98.8K
2
UBS Group
UBS Group
Switzerland
+$10.9K
3
DB
Danske Bank
Denmark
+$30

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$298K
2
BlackRock
BlackRock
New York
-$85.4K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$65K
4
Renaissance Technologies
Renaissance Technologies
New York
-$38.9K
5
State Street
State Street
Massachusetts
-$21.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Corient Private Wealth
1
Corient Private Wealth
Florida
$86.5K +$98.8K +10,011 New
UBS Group
2
UBS Group
Switzerland
$10.2K +$10.9K +1,104 +1,415%
Morgan Stanley
3
Morgan Stanley
New York
$6.59K -$10 -1 -0.1%
CB
4
Community Bank
New York
$1.14K – – –
HI
5
Harbour Investments
Wisconsin
$87 – – –
HI
6
Hoey Investments
Pennsylvania
$87 – – –
Osaic Holdings
7
Osaic Holdings
Arizona
$86 – – –
Bank of America
8
Bank of America
North Carolina
$43 – – –
Wells Fargo
9
Wells Fargo
California
$35 – – –
DB
10
Danske Bank
Denmark
$26 +$30 +3 New
SPIA
11
Steward Partners Investment Advisory
New York
$17 – – –
FFA
12
Farther Finance Advisors
California
$9 -$10 -1 -50%
Vanguard Group
13
Vanguard Group
Pennsylvania
– -$298K -24,468 Closed
BlackRock
14
BlackRock
New York
– -$85.4K -6,990 Closed
Geode Capital Management
15
Geode Capital Management
Massachusetts
– -$65K -5,319 Closed
Renaissance Technologies
16
Renaissance Technologies
New York
– -$38.9K -3,183 Closed
State Street
17
State Street
Massachusetts
– -$21.2K -1,733 Closed
Verition Fund Management
18
Verition Fund Management
Connecticut
– -$19.8K -1,622 Closed
Northern Trust
19
Northern Trust
Illinois
– -$10.4K -852 Closed
XT
20
XTX Topco
Cayman Islands
– -$10.2K -836 Closed
Citadel Advisors
21
Citadel Advisors
Florida
– -$5.95K -487 Closed
CGA
22
Crescent Grove Advisors
Illinois
– -$5.55K -454 Closed
SWM
23
SeaCrest Wealth Management
New York
– -$4.29K -351 Closed
TSS
24
Two Sigma Securities
New York
– -$2.53K -207 Closed
CAPTRUST Financial Advisors
25
CAPTRUST Financial Advisors
North Carolina
– -$2.45K -200 Closed
1
2

AIM Hedge Fund Activity: Q2 2025 in Review

12 of the 7,604 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q2 2025, worth a combined $105K — down 82% from $590K a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of AIM and 2 opened new positions — a net loss of 20 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Corient Private Wealth, opening a new position worth an estimated $98.8K. The largest seller was Vanguard Group, exiting entirely with an estimated $298K sold.

  • 12 institutional investors held AIM ImmunoTech (AIM) as of Q2 2025, down from 32 in Q1 2025.
  • Funds reported $105K of AIM ImmunoTech stock for Q2 2025, down 82% quarter-over-quarter.
  • 2 funds opened new AIM ImmunoTech positions in Q2 2025 and 22 closed out, a net change of -20 holders.
  • The largest AIM ImmunoTech buyer in Q2 2025 was Corient Private Wealth, an estimated $98.8K added.
  • The largest AIM ImmunoTech seller in Q2 2025 was Vanguard Group, an estimated $298K sold.

Based on aggregated 13F filings for Q2 2025.